CIK 0001582313
- Large accelerated filer
Xenon Pharmaceuticals Inc.
Sign in to watch- Ticker
- XENE
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- British Columbia, Canada
- Entity type
- Operating
- EIN
- 980661854
- Phone
- +1 604-484-3300
- Business address
- 200 - 3650 GILMORE WAY, BURNABY, British Columbia, Canada
- Open-market buys, last 90 days
- $1,681,140
- in 2 filings
- Open-market sales, last 90 days
- $425,829
- in 1 filing, $426K under 10b5-1 plans
Net +$1,255,311. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
Reading 36 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2026-08-11 | GANNON STEVEN Director | Sale | −10,000 | $64.06 | $641K | 1,870 |
| 2026-06-03 | GANNON STEVEN Director | Grant or award · Share Option (Right to Buy) | +10,507 | 10,507 | ||
| 2026-06-03 | GANNON STEVEN Director | Grant or award · Restricted Share Units | +1,593 | 1,593 | ||
| 2026-06-01 | GANNON STEVEN Director | Exercise or conversion | +2,645 | 13,286 | ||
| 2026-06-01 | GANNON STEVEN Director | Shares withheld for taxes | −1,416 | $53.41 | $76K | 11,870 |
| 2026-06-01 | GANNON STEVEN Director | Exercise or conversion · Restricted Share Units | −2,645 | 0 | ||
| 2026-05-12 | GANNON STEVEN Director | Exercise or conversion | +3,500 | $7.38 | $26K | 10,641 |
| 2026-05-12 | GANNON STEVEN Director | Exercise or conversion · Stock Option (Right to Buy) | −3,500 | 0 | ||
| 2025-06-05 | GANNON STEVEN Director | Sale | −3 | $30.48 | $91 | 7,141 |
| 2025-06-05 | GANNON STEVEN Director | Grant or award · Share Option (Right to Buy) | +17,012 | 17,012 | ||
| 2025-06-05 | GANNON STEVEN Director | Grant or award · Restricted Share Units | +2,645 | 2,645 | ||
| 2025-05-14 | GANNON STEVEN Director | Exercise or conversion | +5,144 | $12.57 | $65K | 7,144 |
| 2025-05-14 | GANNON STEVEN Director | Exercise or conversion · Stock Option (Right to Buy) | −5,144 | 0 | ||
| 2024-06-05 | GANNON STEVEN Director | Grant or award · Stock Option (Right to Buy) | +15,542 | 15,542 | ||
| 2024-03-07 | GANNON STEVEN Director | Sale | −1,000 | $46.45 | $46K | 14,000 |
| 2024-03-07 | GANNON STEVEN Director | Sale | −5,000 | $46.25 | $231K | 9,000 |
| 2024-03-07 | GANNON STEVEN Director | Sale | −5,000 | $46.30 | $232K | 4,000 |
| 2024-03-07 | GANNON STEVEN Director | Sale | −2,000 | $46.20 | $92K | 2,000 |
| 2023-06-02 | GANNON STEVEN Director | Grant or award · Stock Option (Right to Buy) | +18,475 | 18,475 | ||
| 2022-06-28 | GANNON STEVEN Director | Grant or award · Stock Option (Right to Buy) | +18,000 | 18,000 |
Page 1 of 2 · 28 trades